Efficacy of Phosphatidylserine Enriched With n-3 PUFA Supplementation on ADHD in Children With Epilepsy

Inclusion Criteria: * Children aged 6 to 15 years and 11 months. * Children of either sex (male/female) suffering from epilepsy regardless of syndrome classification. * Subjects on a stable dose of antiepileptic drugs (AED) for at least one month prior to inclusion and subjects for whom no change is considered a priori for the three months following the inclusion. * Diagnosis of ADHD inattention or mixed type according to the DSM V criteria. * Subjects must agree to study participation and their parents/legal guardian must provide written inform consent prior to participation in the study. Exclusion Criteria: * Subjects less than 6 years or older than 16 years old * AED not stable for at least one month and/or a change in AED is expected in the three months following inclusion. * Diagnosis of ADHD hyperactivity type exclusive according to DSM V criteria. * Mental retardation defined by a score \< 70 on the verbal comprehension and perceptual reasoning Wechsler Intelligence Scale for Children - Fourth Edition (WISC-IV), performed within 18 months prior to inclusion or at V1. * Diagnosis of a psychiatric comorbidity other than ADHD according to the DSM V criteria, including: pervasive developmental disorders including autism disorders; bipolar disordersand psychotic disorders. * Children suffering from diabetes, any type. * Use of psychoactive drugs in ADHD within the previous month: Methylphenidate, Amphetamine, Atomoxetine, Modafinil and Antidepressants whatever the class.…